Crispr Therapeutics shares owned by WS Management
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by WS Management
from 13F filings
Historical chart of WS Management investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by WS Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Crispr Therapeutics by WS Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-09-30 | $857k | 19k | 45.39 |
| 2023-06-30 | $1.1M | 19k | 56.14 |
| 2023-03-31 | $854k | 19k | 45.23 |
| 2022-12-31 | $767k | 19k | 40.65 |
| 2022-09-30 | $1.2M | 19k | 65.37 |
| 2022-06-30 | $1.1M | 19k | 60.77 |
| 2022-03-31 | $1.2M | 19k | 62.78 |
| 2021-12-31 | $1.4M | 19k | 75.76 |
| 2021-09-30 | $2.1M | 19k | 111.94 |
| 2021-06-30 | $3.1M | 19k | 161.90 |
| 2021-03-31 | $2.3M | 19k | 121.85 |
| 2020-12-31 | $3.0M | 20k | 153.13 |
| 2020-09-30 | $1.7M | 20k | 83.62 |
| 2020-06-30 | $1.5M | 20k | 73.49 |
| 2020-03-31 | $986k | 23k | 42.41 |
| 2019-12-31 | $1.5M | 24k | 60.89 |
| 2019-09-30 | $1.0M | 24k | 40.99 |
| 2019-06-30 | $1.3M | 27k | 47.10 |
| 2019-03-31 | $1.1M | 30k | 35.72 |
| 2018-12-31 | $983k | 34k | 28.58 |
| 2018-09-30 | $2.5M | 57k | 44.35 |
| 2018-06-30 | $3.3M | 57k | 58.75 |